[1] A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study

[2] Intensive intervention can lead to a treatment holiday from biological DMARDs in patients with rheumatoid arthritis

[3] Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial

[4] Risk of losing remission, low disease activity or radiographic progression in case of bDMARD discontinuation or tapering in rheumatoid arthritis: systematic analysis of the literature and meta-analysis

[5] [Rheumatoid arthritis as a connective tissue disease]

[6] Early, Incomplete, or Preclinical Autoimmune Systemic Rheumatic Diseases and Pregnancy Outcome

[7] [Rheumatoid arthritis in elderly people]

[8] Diastolic dysfunction in rheumatoid arthritis patients with low disease activity

[9] [Early reumatoid arthritis]

[10] The impact of the current epidemiology of pediatric musculoskeletal infection on evaluation and treatment guidelines

[11] The "Treat to Target" Approach to Rheumatoid Arthritis

[12] [Clinical and ultrasound assessment of the disease activity in patients with rheumatoid arthritis]

[13] Cryptotanshinone induces reactive oxygen species‑mediated apoptosis in human rheumatoid arthritis fibroblast‑like synoviocytes

[14] Gender Differences in Cardiovascular Risk Profile in Rheumatoid Arthritis Patients with Low Disease Activity

[15] [Discontinuation or tapering strategies of biologics in rheumatoid arthritis in remission]

[16] Cardiovascular system changes in rheumatoid arthritis patients with continued low disease activity

[17] Prospective assessment of cardiovascular risk parameters in patients with rheumatoid arthritis

[18] Relationship between the effect of cyclophosphamide on adjuvant arthritis severity, skin allograft rejection and spleen cell cytotoxic activity in rats

[19] The advanced glycation end product pentosidine correlates to IL-6 and other relevant inflammatory markers in rheumatoid arthritis

[20] [Hemangioblastoma associated with syringomyelia and syringobulbia in a patient with rheumatoid arthritis]

[21] Uptake of chloroquine and hydroxychloroquine by human blood leucocytes in vitro: relation to cellular concentrations during antirheumatic therapy

[22] Baricitinib for the treatment of rheumatoid arthritis and systemic lupus erythematosus: a 2019 update

[23] Alleviation of collagen-induced arthritis by the benzoxathiole derivative BOT-4-one in mice: Implication of the Th1- and Th17-cell-mediated immune responses.

[24] Quality of life in psoriatic arthritis patients-association with disease activity and diagnostic delay time

[25] Impact of psychological factors on subjective disease activity assessments in patients with severe rheumatoid arthritis.

[26] Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort.

[27] High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis.

[28] Correlation of C-reactive protein haplotypes with serum C-reactive protein level and response to anti-tumor necrosis factor therapy in UK rheumatoid arthritis patients: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort.

[29] Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk.

[30] PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population.

[31] Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13.

[32] A Comparative Study of Interleukin 6, Inflammatory Markers, Ferritin, and Hematological Profile in Rheumatoid Arthritis Patients with Anemia of Chronic Disease and Iron Deficiency Anemia

[33] Galectin-1, -4, and -7 Were Associated with High Activity of Disease in Patients with Rheumatoid Arthritis

[34] Concordance between the Different Cardiovascular Risk Scores in People with Rheumatoid Arthritis and Psoriasis Arthritis

[35] Medication Adherence and Coping Strategies in Patients with Rheumatoid Arthritis: A Cross-Sectional Study

[36] Occipital and external acoustic meatus to axis angle: a useful predictor of oropharyngeal space in rheumatoid arthritis patients with atlantoaxial subluxation.

[37] Association between plasminogen activator inhibitor‑1 (PAI-1) 4G/5G polymorphism and circulating PAI-1 level in systemic lupus erythematosus and rheumatoid arthritis : A meta-analysis.

[38] QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS - A PRELIMINARY STUDY.

[39] Vitamin D Receptor Polymorphism and DHCR7 Contribute to the Abnormal Interplay Between Vitamin D and Lipid Profile in Rheumatoid Arthritis

[40] Renal function and cardiovascular risk in rheumatoid arthritis

[41] Respiratory viral infections and the risk of rheumatoid arthritis.

[42] Prevalence of methotrexate intolerance among patients with rheumatoid arthritis using the Arabic version of the methotrexate intolerance severity score.

[43] Crosstalk between Fas and S1P<inf>1</inf> signaling via NF-kB in osteoclasts controls bone destruction in the TMJ due to rheumatoid arthritis

[44] Three-dimensional assessment of facial morphology in children and adolescents with juvenile idiopathic arthritis and moderate to severe TMJ involvement using 3D surface scans

[45] Assessment of interstitial lung disease among black rheumatoid arthritis patients.

[46] Potential mechanisms linking periodontitis to rheumatoid arthritis.

[47] Mayaro Virus Infects Human Chondrocytes and Induces the Expression of Arthritis-Related Genes Associated with Joint Degradation.

[48] Therapeutic benefits of Indole-3-Carbinol in adjuvant-induced arthritis and its protective effect against methotrexate induced-hepatic toxicity.

[49] Machine-learning based knowledge discovery in rheumatoid arthritis related registry data to identify predictors of persistent pain.

[50] Characterization of rheumatoid arthritis subtypes using symptom profiles, clinical chemistry and metabolomics measurements.

[51] Affinity maturation shapes the function of agonistic antibodies to peptidylarginine deiminase type 4 in rheumatoid arthritis.

[52] Antibodies directed against endogenous and exogenous citrullinated antigens pre-date the onset of rheumatoid arthritis.

[53] Polymorphisms in peptidylarginine deiminase associate with rheumatoid arthritis in diverse Asian populations: evidence from MyEIRA study and meta-analysis.

[54] Effectiveness of subcutaneously administered methotrexate in patients with rheumatoid arthritis.

[55] Pre-conception status, obstetric outcome and use of medications during pregnancy of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) in Japan: multi-center retrospective descriptive study.

[56] Efficacy and Safety of Multiple Dosages of Fostamatinib in Adult Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.

[57] No increase in the risk of autism spectrum disorder in children born to mothers with systemic lupus erythematosus and rheumatoid arthritis

[58] Collagen II-primed Foxp3 Transduced T Cells Ameliorate Collagen-induced Arthritis in Rats: The Effect of Antigenic Priming on T Regulatory Cell Function.

[59] Investigation of the cytokine response to NF-ΚB decoy oligonucleotide coated polysaccharide based nanoparticles in rheumatoid arthritis in vitro models

[60] Opuntioside, opuntiol and its metallic nanoparticles attenuate adjuvant-induced arthritis: Novel suppressors of Toll-like receptors -2 and -4.

[61] Proteomics Approach for the Discovery of Rheumatoid Arthritis Biomarkers Using Mass Spectrometry.

[62] A case study applying a novel approach to estimate the social impact of a medical innovation - the use of secukinumab for psoriatic arthritis in Germany.

[63] Comparison of oral versus parenteral methotrexate in the treatment of rheumatoid arthritis: A meta-analysis.

[64] Nigella sativa fixed oil as alternative treatment in management of pain in arthritis rheumatoid.

[65] Salivary gland involvement and oxidative stress in juvenile idiopathic arthritis: Novel observation in oligoarticular-type patients

[66] Salivary gland involvement in rheumatoid arthritis and its relationship to induced oxidative stress

[67] Prevalence of feet and ankle arthritis and their impact on clinical indices in patients with rheumatoid arthritis: a cross-sectional study.

[68] Macrophage M1/M2 polarization and rheumatoid arthritis: A systematic review.

[69] Clinico-genetic model to predict methotrexate intolerance in rheumatoid arthritis.

[70] Chikungunya arthritis.

[71] The potential value of rapid, cloud-enabled onsite testing for the diagnosis of rheumatoid arthritis in the United States.

[72] First Validation of the Full PROMIS Pain Interference and Pain Behavior Item Banks in Patients with Rheumatoid Arthritis.

[73] Neonatal septic arthritis: Indian perspective.

[74] The Influence of Allowable Refill Gaps on Detecting Long-Term Opioid Therapy: An Analysis of Population-Based Administrative Dispensing Data Among Patients with Knee Arthritis Awaiting Total Knee Arthroplasty.

[75] Acute gouty arthritis and rapidly progressive renal failure as manifestation of multiple myeloma: clinical case description

[76] Analysis of intestinal immunity and flora in a collagen-induced mouse arthritis model: differences during arthritis progression.

[77] Mobile Health Features Supporting Self-Management Behavior in Patients With Chronic Arthritis: Mixed-Methods Approach on Patient Preferences.

[78] Additive effects of inhibiting both mTOR and glutamine metabolism on the arthritis in SKG mice

[79] Сase Report of Acute Toxic Imatinib-induced Hepatitis in a Patient with Chronic Myeloid Leukemia, Sulfa Allergy, and Rheumatoid Arthritis.

[80] Are we really what we eat? Nutrition and its role in the onset of rheumatoid arthritis.

[81] Linking systemic angiogenic markers to synovial vascularization in rheumatoid arthritis.

[82] The Microbiome in Psoriasis and Psoriatic Arthritis: The Skin Perspective.

[83] Adjunctive vitamin D for the treatment of active juvenile idiopathic arthritis: An open-label, prospective, randomized controlled trial.

[84] An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis

[85] Analgesic and antiinflammatory effects of dipyrone in rat adjuvant arthritis model.

[86] Use of FDA-Approved Medications: Biologics for Psoriatic Arthritis in Patients at an Urban Outpatient Rheumatology Clinic.

[87] A criterion-based approach to systematic and transparent comparative effectiveness: a case study in psoriatic arthritis.

[88] Methotrexate Restores CD73 Expression on Th1.17 in Rheumatoid Arthritis and Psoriatic Arthritis Patients and May Contribute to Its Anti-Inflammatory Effect through Ado Production.

[89] Therapeutic effect of a novel histone deacetylase 6 inhibitor, CKD-L, on collagen-induced arthritis in vivo and regulatory T cells in rheumatoid arthritis in vitro

[90] What potential do magnetic iron oxide nanoparticles have for the treatment of rheumatoid arthritis?

[91] Enthesitis and its relationship with disease activity, functional status, and quality of life in psoriatic arthritis: a multi-center study.

[92] Regulation of T Cell Function by Reactive Nitrogen and Oxygen Species in Collagen-Induced Arthritis.

[93] Synovial tissue quantitative proteomics analysis reveals paeoniflorin decreases LIFR and ASPN proteins in experimental rheumatoid arthritis.

[94] Sequential alterations in catabolic and anabolic gene expression parallel pathological changes during progression of monoiodoacetate-induced arthritis.

[95] Role of Interleukin 6 Inhibitors in the Management of Rheumatoid Arthritis.

[96] Effect of Moxibustion on HIF-1 and VEGF Levels in Patients with Rheumatoid Arthritis.

[97] Long-term results of modified ligament reconstruction and tendon interposition for thumb basal joint arthritis.

[98] Dose-Dependent Efficacy of Gold Clusters on Rheumatoid Arthritis Therapy.

[99] Impact of collagen-induced arthritis on the pharmacokinetic disposition of voriconazole, a widely used antifungal agent: in vitro and in vivo investigations in DBA/1J mice.

[100] Synovial-Fluid miRNA Signature for Diagnosis of Juvenile Idiopathic Arthritis.

[101] Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.